Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis.

[1]  J. Baker,et al.  Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin , 1988, The Journal of cell biology.

[2]  L. Ossowski.  Plasminogen activator dependent pathways inthe dissemination of human tumor cells in the chick embryo , 1988, Cell.

[3]  D. Farrell,et al.  Localization of protease nexin‐1 on the fibroblast extracellular matrix , 1988, Journal of cellular physiology.

[4]  A. Vaheri,et al.  Ultrastructural localization of plasma membrane-associated urokinase- type plasminogen activator at focal contacts , 1988, The Journal of cell biology.

[5]  M. Laiho,et al.  Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. , 1987, The Journal of biological chemistry.

[6]  Bonnie F. Sloane,et al.  Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants. , 1987, Cancer research.

[7]  K. Hajjar,et al.  Binding of tissue plasminogen activator to cultured human endothelial cells. , 1987, The Journal of clinical investigation.

[8]  L. Orci,et al.  Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells , 1987, The Journal of cell biology.

[9]  E. Levin,et al.  Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells , 1987, The Journal of cell biology.

[10]  T. Salo,et al.  Proteolytic degradation of extracellular matrix in tumor invasion. , 1987, Biochimica et biophysica acta.

[11]  P. Stephens,et al.  Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. , 1987, The Biochemical journal.

[12]  M. Fini,et al.  Cloning of a complementary DNA for rabbit proactivator. A metalloproteinase that activates synovial cell collagenase, shares homology with stromelysin and transin, and is coordinately regulated with collagenase. , 1987, Arthritis and rheumatism.

[13]  E. Plow,et al.  Receptor Mediated Binding of the Fibrinolytic Components, Plasminogen and Urokinase, to Peripheral Blood Cells , 1987, Thrombosis and Haemostasis.

[14]  R. Nachman,et al.  Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. , 1987, The Journal of clinical investigation.

[15]  R. H. Gross,et al.  A gene for rabbit synovial cell collagenase: member of a family of metalloproteinases that degrade the connective tissue matrix. , 1987, Biochemistry.

[16]  E. Crouch,et al.  Degradation of native type IV procollagen by human neutrophil elastase. Implications for leukocyte-mediated degradation of basement membranes. , 1987, Biochemistry.

[17]  J. Starkey,et al.  Comparison of basement membrane matrix degradation by purified proteases and by metastatic tumor cells , 1987, Journal of cellular biochemistry.

[18]  L. Orci,et al.  Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors , 1987, Journal of cellular physiology.

[19]  J. Mimuro,et al.  Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor. , 1987, Blood.

[20]  B. Binder,et al.  Proliferation of a human epidermal tumor cell line stimulated by urokinase , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  D. Moscatelli,et al.  The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells , 1987, The Journal of cell biology.

[22]  M. T. Brewer,et al.  A form of human basic fibroblast growth factor with an extended amino terminus. , 1987, Biochemical and biophysical research communications.

[23]  S. Zucker,et al.  Metastatic mouse melanoma cells release collagen-gelatin degrading metalloproteinases as components of shed membrane vesicles. , 1987, Biochimica et biophysica acta.

[24]  C. Gabrielides,et al.  A vertebrate interstitial collagenase inhibitor from bovine scapular cartilage: purification and characterization. , 1987, Biochimica et biophysica acta.

[25]  T. Kooistra,et al.  Effect of Thrombin on the Production of Plasminogen Activators and PA Inhibitor-1 by Human Foreskin Microvascular Endothelial Cells , 1987, Thrombosis and Haemostasis.

[26]  E. Appella,et al.  The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. , 1987, The Journal of biological chemistry.

[27]  A. Vaheri,et al.  Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells , 1987, The Journal of cell biology.

[28]  D. Gospodarowicz,et al.  Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells. , 1987, Biochemical and biophysical research communications.

[29]  S. Zucker,et al.  Enrichment of collagen and gelatin degrading activities in the plasma membranes of human cancer cells. , 1987, Cancer research.

[30]  W. Hahn,et al.  Mesosecrin: a secreted glycoprotein produced in abundance by human mesothelial, endothelial, and kidney epithelial cells in culture , 1987, The Journal of cell biology.

[31]  L. Orci,et al.  Phorbol esters induce angiogenesis in vitro from large‐vessel endothelial cells , 1987, Journal of cellular physiology.

[32]  Wen‐Tien Chen,et al.  Fibronectin-degrading proteases from the membranes of transformed cells , 1987, Cell.

[33]  D. Cunningham,et al.  Binding sites for elastase on cultured human fibroblasts that do not mediate internalization , 1987, Journal of cellular physiology.

[34]  J. Plescia,et al.  The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type , 1986, The Journal of cell biology.

[35]  M. Laiho,et al.  Enhanced production and extracellular deposition of the endothelial- type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta , 1986, The Journal of cell biology.

[36]  D. Rifkin,et al.  Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade , 1986, Cell.

[37]  M. Presta,et al.  Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration , 1986, Molecular and cellular biology.

[38]  L. Liotta,et al.  Proteolytic Enzymes in Cancer Invasion and Metastasis , 1986, Seminars in thrombosis and hemostasis.

[39]  E. Jaffe,et al.  Binding of plasminogen to cultured human endothelial cells. , 1986, The Journal of biological chemistry.

[40]  S. Schwartz,et al.  Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. , 1986, Science.

[41]  R. Silverstein,et al.  Binding of plasminogen to extracellular matrix. , 1986, The Journal of biological chemistry.

[42]  V. Schirrmacher,et al.  Involvement of both heparanase and plasminogen activator in lymphoma cell‐mediated degradation of heparan sulfate in the subendothelial extracellular matrix , 1986, Journal of cellular physiology.

[43]  R. Cappelletti,et al.  Heparan sulfate endoglycosidase and metastatic potential in murine fibrosarcoma and melanoma. , 1986, Cancer research.

[44]  L. Ostrowski,et al.  Inhibition of proteolytic enzymes in the in vitro amnion model for basement membrane invasion. , 1986, Cancer research.

[45]  A. Baird,et al.  Inhibition of endothelial cell proliferation by type beta-transforming growth factor: interactions with acidic and basic fibroblast growth factors. , 1986, Biochemical and biophysical research communications.

[46]  Y. DeClerck,et al.  Inhibition of tumor cell collagenolytic activity by bovine endothelial cells. , 1986, Cancer research.

[47]  B. Olwin,et al.  Identification of the fibroblast growth factor receptor of Swiss 3T3 cells and mouse skeletal muscle myoblasts. , 1986, Biochemistry.

[48]  R. Shapiro,et al.  Characteristic ribonucleolytic activity of human angiogenin. , 1986, Biochemistry.

[49]  E. Appella,et al.  Autocrine saturation of pro-urokinase receptors on human A431 cells , 1986, Cell.

[50]  R. Derynck,et al.  Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. , 1986, Science.

[51]  J. McCarthy,et al.  Clearing and release of basement membrane proteins from substrates by metastatic tumor cell variants. , 1986, Cancer research.

[52]  W. Birchmeier,et al.  Transforming growth factor-beta inhibits endothelial cell proliferation. , 1986, Biochemical and biophysical research communications.

[53]  B. Spiegelman,et al.  Heparin potentiation of 3T3‐adipocyte stimulated angiogenesis: Mechanisms of action on endothelial cells , 1986, Journal of cellular physiology.

[54]  E. Levin.  Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells , 1986 .

[55]  D. Gospodarowicz,et al.  Basic and acidic fibroblast growth factors interact with the same cell surface receptors. , 1986, The Journal of biological chemistry.

[56]  D. Gospodarowicz,et al.  Effect of fibroblast growth factor and lipoproteins on the proliferation of endothelial cells derived from bovine adrenal cortex, brain cortex, and corpus luteum capillaries , 1986, Journal of cellular physiology.

[57]  R. Kramer,et al.  Invasion of reconstituted basement membrane matrix by metastatic human tumor cells. , 1986, Cancer research.

[58]  C. Yee,et al.  Degradation of endothelial basement membrane by human breast cancer cell lines. , 1986, Cancer research.

[59]  R. Langer,et al.  Purification and partial amino acid sequence of a bovine cartilage-derived collagenase inhibitor. , 1986, The Journal of biological chemistry.

[60]  G. Giménez-Gallego,et al.  Human brain-derived acidic and basic fibroblast growth factors: amino terminal sequences and specific mitogenic activities. , 1986, Biochemical and biophysical research communications.

[61]  J. Harper,et al.  Amino acid sequence of bovine brain derived class 1 heparin-binding growth factor. , 1986, Biochemistry.

[62]  M J Banda,et al.  Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. , 1986, The Journal of biological chemistry.

[63]  Z. Werb,et al.  Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. , 1986, The Journal of biological chemistry.

[64]  M. Klagsbrun,et al.  Purification and characterization of heparin-binding endothelial cell growth factors. , 1986, The Journal of biological chemistry.

[65]  G. Giménez-Gallego,et al.  Brain-derived acidic fibroblast growth factor: complete amino acid sequence and homologies. , 1985, Science.

[66]  N. Ling,et al.  Primary structure of bovine brain acidic fibroblast growth factor (FGF). , 1985, Biochemical and biophysical research communications.

[67]  J. Baker,et al.  Cryptic urokinase binding sites on human foreskin fibroblasts. , 1985, Biochemical and biophysical research communications.

[68]  S. Zucker,et al.  Diversity of human pancreatic cancer cell proteinases: role of cell membrane metalloproteinases in collagenolysis and cytolysis. , 1985, Cancer research.

[69]  P. Bohlen,et al.  Corpus luteum angiogenic factor is related to fibroblast growth factor. , 1985, Endocrinology.

[70]  V. Terranova,et al.  Human endothelial cells are chemotactic to endothelial cell growth factor and heparin , 1985, The Journal of cell biology.

[71]  J. Reynolds,et al.  Inhibition of type I collagen film degradation by tumour cells using a specific antibody to collagenase and the specific tissue inhibitor of metalloproteinases (TIMP). , 1985, Cell Biology International Reports.

[72]  O. Saksela,et al.  Plasminogen activation and regulation of pericellular proteolysis. , 1985, Biochimica et biophysica acta.

[73]  J. Quigley,et al.  The extracellular matrix of normal chick embryo fibroblasts: its effect on transformed chick fibroblasts and its proteolytic degradation by the transformants , 1985, The Journal of cell biology.

[74]  Z. Werb,et al.  Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates. , 1985, The Journal of biological chemistry.

[75]  J. Zeuthen,et al.  Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin. , 1985, The Journal of biological chemistry.

[76]  D. Loskutoff,et al.  Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. , 1985, The Journal of biological chemistry.

[77]  J F Riordan,et al.  Amino acid sequence of human tumor derived angiogenin. , 1985, Biochemistry.

[78]  K. Kurachi,et al.  Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor. , 1985, Biochemistry.

[79]  J. L. Bethune,et al.  Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. , 1985, Biochemistry.

[80]  D. J. Strydom,et al.  Comparison of human and bovine brain derived heparin-binding growth factors. , 1985, Biochemical and biophysical research communications.

[81]  R. Lobb,et al.  Induction of angiogenesis by bovine brain derived class 1 heparin-binding growth factor. , 1985, Biochemistry.

[82]  L. Orci,et al.  Tumor-promoting phorbol esters induce angiogenesis in vitro , 1985, Cell.

[83]  M. Presta,et al.  Human placental tissue stimulates bovine capillary endothelial cell growth, migration and protease production , 1985, Bioscience reports.

[84]  W. Laug,et al.  Endothelial Cells Degrade Extracellular Matrix Proteins Produced In Vitro , 1985, Thrombosis and Haemostasis.

[85]  R. Silverstein,et al.  Activation of immobilized plasminogen by tissue activator. Multimolecular complex formation. , 1985, The Journal of biological chemistry.

[86]  D. Gospodarowicz,et al.  Acidic fibroblast growth factor (FGF) from bovine brain: amino‐terminal sequence and comparison with basic FGF. , 1985, The EMBO journal.

[87]  Z. Fuks,et al.  Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells , 1985, International journal of cancer.

[88]  E. Plow,et al.  Binding and activation of plasminogen on the platelet surface. , 1985, The Journal of biological chemistry.

[89]  Z. Fuks,et al.  Characterization of an extracellular matrix-degrading protease derived from a highly metastatic tumor cell line. , 1985, European journal of cancer & clinical oncology.

[90]  J. Seyer,et al.  Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. , 1985, The Journal of biological chemistry.

[91]  W. Reilly,et al.  New functions of epidermal growth factor: stimulation of capillary endothelial cell migration and matrix dependent proliferation. , 1985, Cell biology international reports.

[92]  D. Moscatelli,et al.  Production of latent collagenase by human umbilical vein endothelial cells in response to angiogenic preparations. , 1985, Experimental cell research.

[93]  D. Belin,et al.  A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase , 1985, The Journal of cell biology.

[94]  R. Lobb,et al.  Purification of two distinct growth factors from bovine neural tissue by heparin affinity chromatography. , 1984, Biochemistry.

[95]  D. Lawrence,et al.  Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells. , 1984, The Journal of biological chemistry.

[96]  S. Krane,et al.  Regulation of the mammalian collagenases. , 1984, Collagen and related research.

[97]  K. Moon,et al.  Serine proteinase activation of latent human skin collagenase. , 1984, Biochemical and biophysical research communications.

[98]  G. Conn,et al.  The isolation and purification of two anionic endothelial cell growth factors from human brain. , 1984, Biochemical and biophysical research communications.

[99]  M. Klagsbrun,et al.  Endothelial cell mitogens derived from retina and hypothalamus: biochemical and biological similarities , 1984, The Journal of cell biology.

[100]  H. Chapman,et al.  Co-operation between plasmin and elastase in elastin degradation by intact murine macrophages. , 1984, The Biochemical journal.

[101]  A. Schreiber,et al.  Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain. , 1984, Science.

[102]  C. Handley,et al.  Changes in proteoglycan biosynthesis following leukocyte elastase treatment of bovine articular cartilage in culture. , 1984, Arthritis and rheumatism.

[103]  G. Osikowicz,et al.  Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase. , 1984, The Journal of biological chemistry.

[104]  D. Rosberger,et al.  Synthesis of biologically active rat transforming growth factor I , 1984, Nature.

[105]  D. Rifkin,et al.  Stimulation of motility in cultured bovine capillary endothelial cells by angiogenic preparations , 1984, Journal of cellular physiology.

[106]  W. T. Chen,et al.  Expression of transformation-associated protease(s) that degrade fibronectin at cell contact sites , 1984, The Journal of cell biology.

[107]  J. Folkman,et al.  Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. , 1984, Science.

[108]  K. Danø,et al.  Human endothelial cells contain one type of plasminogen activator , 1984, FEBS letters.

[109]  L. Hood,et al.  Rat transforming growth factor type 1: structure and relation to epidermal growth factor. , 1984, Science.

[110]  T. Irimura,et al.  Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. , 1984, The Journal of biological chemistry.

[111]  I. Horváth,et al.  Interaction of plasmin with endothelial cells. , 1984, The Biochemical journal.

[112]  S. Kumar,et al.  Metalloproteinase inhibitors from bovine cartilage and body fluids. , 1984, European journal of biochemistry.

[113]  D. Mullins,et al.  The role of proteinase in cellular invasiveness , 1983 .

[114]  P. Jones,et al.  Inhibition by bovine endothelial cells of degradation by HT-1080 fibrosarcoma cells of extracellular matrix proteins. , 1983, Journal of the National Cancer Institute.

[115]  L. Ossowski,et al.  Antibodies to plasminogen activator inhibit human tumor metastasis , 1983, Cell.

[116]  P. Jones,et al.  Role of plasminogen in matrix breakdown by neoplastic cells. , 1983, Journal of the National Cancer Institute.

[117]  J. Massagué,et al.  Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells. , 1983, The Journal of biological chemistry.

[118]  C. Vater,et al.  Purification of an endogenous activator of procollagenase from rabbit synovial fibroblast culture medium. , 1983, The Journal of biological chemistry.

[119]  E. Hoal,et al.  The regulation of tissue plasminogen activator activity by human fibroblasts , 1983, Cell.

[120]  L. Liotta,et al.  Basement membrane collagen: degradation by migrating endothelial cells. , 1983, Science.

[121]  Z. Fuks,et al.  Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. , 1983, Cancer research.

[122]  T. Irimura,et al.  Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. , 1983, Science.

[123]  R. Isseroff,et al.  Plasminogen is present in the basal layer of the epidermis. , 1983, The Journal of investigative dermatology.

[124]  L. Liotta,et al.  Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells. , 1983, The Journal of biological chemistry.

[125]  L. Liotta,et al.  Tumor invasion and the extracellular matrix. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[126]  D. Moscatelli,et al.  Plasminogen activator and collagenase production by cultured capillary endothelial cells , 1982, The Journal of cell biology.

[127]  L. Liotta,et al.  Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells – role in metastasis , 1982, International journal of cancer.

[128]  R. Senior,et al.  Proteolysis by neutrophils. Relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro. , 1982, The Journal of clinical investigation.

[129]  C. P. Leblond,et al.  Localization of type IV collagen, laminin, heparan sulfate proteoglycan, and fibronectin to the basal lamina of basement membranes , 1982, The Journal of cell biology.

[130]  D. Loskutoff,et al.  Cultured bovine endothelial cells produce both urokinase and tissue- type plasminogen activators , 1982, The Journal of cell biology.

[131]  D. Loskutoff,et al.  Characterization of a plasminogen activator secreted by cultured bovine aortic endothelial cells. , 1982, Biochimica et biophysica acta.

[132]  M. Baggiolini,et al.  Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens. , 1982, The Biochemical journal.

[133]  M. Hoylaerts,et al.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. , 1982, The Journal of biological chemistry.

[134]  M. de Silva,et al.  Identification of plasma kallikrein as an activator of latent collagenase in rheumatoid synovial fluid. , 1982, Biochimica et biophysica acta.

[135]  G. Nicolson,et al.  Solubilization and degradation of subendothelial matrix glycoproteins and proteoglycans by metastatic tumor cells. , 1982, The Journal of biological chemistry.

[136]  H. Chapman,et al.  Macrophage fibrinolytic activity: Identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor , 1982, Cell.

[137]  G. Osikowicz,et al.  Immunological identification and comparison of plasminogen activator forms in cultured normal human endothelial cells and smooth muscle cells. , 1981, Thrombosis research.

[138]  L. Liotta,et al.  Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. , 1981, Cancer research.

[139]  J. Varani,et al.  Substrate hydrolysis by immune complex-activated neutrophils: effect of physical presentation of complexes and protease inhibitors. , 1981, Journal of immunology.

[140]  R. Stephens,et al.  Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator , 1981, International journal of cancer.

[141]  J. Roberts,et al.  Cathepsin B-like enzymes. Subcellular distribution and properties in neoplastic and control cells from human ectocervix. , 1981, The Journal of biological chemistry.

[142]  D. Collen,et al.  Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. , 1981, The Journal of biological chemistry.

[143]  D. Loskutoff,et al.  An Inhibitor Of Plasminogen Activator In Rabbit Endothelial Cells , 1981, Thrombosis and Haemostasis.

[144]  Z. Werb,et al.  Mouse macrophage elastase. Purification and characterization as a metalloproteinase. , 1981, The Biochemical journal.

[145]  J. Tyler,et al.  The activation of latent pig synovial collagenase. , 1981, Biochimica et biophysica acta.

[146]  L. Liotta,et al.  Partial purification and characterization of a neutral protease which cleaves type IV collagen. , 1981, Biochemistry.

[147]  S. Itzhaki,et al.  A trypsin-like neutral protease on Ehrlich ascites cell surfaces: its role in the activation of tumour-cell zymogen of collagenase. , 1980, British Journal of Cancer.

[148]  P. Jones,et al.  Destruction of extracellular matrices containing glycoproteins, elastin, and collagen by metastatic human tumor cells. , 1980, Cancer research.

[149]  D. Rijken,et al.  Relationship between tissue plasminogen activator and the activators in blood and vascular wall. , 1980, Thrombosis research.

[150]  A. Kang,et al.  Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules. , 1980, The Journal of biological chemistry.

[151]  D. Rifkin,et al.  Tetradecanoyl phorbol acetate stimulates latent collagenase production by cultured human endothelial cells , 1980, Cell.

[152]  H. Hechtman,et al.  Plasminogen activator activity of isolated cardiac muscle microvessel endothelial cells. , 1980, Thrombosis research.

[153]  L. Liotta,et al.  Activation of human breast carcinoma collagenase through plasminogen activator. , 1980, Life sciences.

[154]  L. Liotta,et al.  Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.

[155]  H. Hechtman,et al.  Plasminogen activator activity by cultured bovine aortic endothelial cells. , 1980, Life sciences.

[156]  W. Benedict,et al.  Anchorage independent growth and plasminogen activator production by bovine endothelial cells , 1980, The Journal of cell biology.

[157]  D. Gospodarowicz,et al.  The angiogenic activity of the fibroblast and epidermal growth factor. , 1979, Experimental eye research.

[158]  K. Alitalo,et al.  Isolation of the pericellular matrix of human fibroblast cultures , 1979, The Journal of cell biology.

[159]  D. Gospodarowicz,et al.  Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin , 1978, The Journal of cell biology.

[160]  E. Dupuy,et al.  Production of a fibrinolytic inhibitor by cultured endothelial cells derived from human umbilical vein. , 1978, Thrombosis research.

[161]  A. Barrett,et al.  Proteinase inhibitors of bovine nasal cartilage. , 1978, The Biochemical journal.

[162]  S. Thorsen.  Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids. , 1977, Danish medical bulletin.

[163]  G. Vaes,et al.  Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. , 1977, The Biochemical journal.

[164]  J. Folkman,et al.  Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. , 1977, Microvascular research.

[165]  B. Marczynska,et al.  Tumor cell collagenase and its inhibition by a cartilage-derived protease inhibitor. , 1977, Science.

[166]  Z. Werb,et al.  Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. , 1977, The New England journal of medicine.

[167]  A. Eisen,et al.  Human skin collagenase: isolation of precursor and active forms from both fibroblast and organ cultures. , 1977, Biochemistry.

[168]  J. Woessner.  A latent form of collagenase in the involuting rat uterus and its activation by a serine proteinase. , 1977, The Biochemical journal.

[169]  R. Crystal,et al.  Activation of alveolar macrophage collagenase by a neutral protease secreted by the same cell , 1976, Nature.

[170]  N. Sorgente,et al.  Cell surface-associated and released proteolytic activities of bovine aorta endothelial cells. , 1976, Biochemical and biophysical research communications.

[171]  J. Quigley.  Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells , 1976, The Journal of cell biology.

[172]  R. Langer,et al.  Isolations of a cartilage factor that inhibits tumor neovascularization. , 1976, Science.

[173]  A. Barrett,et al.  Human lysosomal elastase. Catalytic and immunological properties. , 1976, The Biochemical journal.

[174]  S Gordon,et al.  Elastase secretion by stimulated macrophages. Characterization and regulation , 1975, The Journal of experimental medicine.

[175]  N. Sorgente,et al.  The resistance of certain tissues to invasion. II. Evidence for extractable factors in cartilage which inhibit invasion by vascularized mesenchyme. , 1975, Laboratory investigation; a journal of technical methods and pathology.

[176]  J. Folkman,et al.  Inhibition of tumor angiogenesis mediated by cartilage , 1975, The Journal of experimental medicine.

[177]  L. Ossowski,et al.  Plasminogen, the serum proenzyme activated by factors from cells transformed by oncogenic viruses. , 1974, The Journal of biological chemistry.

[178]  K. Ohlsson,et al.  The Neutral Proteases of Human Granulocytes , 1974 .

[179]  N. Sorgente,et al.  The resistance of certain tissues to invasion: penetrability of explanted tissues by vascularized mesenchyme. , 1973, The American journal of pathology.

[180]  H. Shepard,et al.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α , 1987, Nature.

[181]  D. Moscatelli.  Urokinase‐type and tissue‐type plasminogen activators have different distributions in cultured bovine capillary endothelial cells , 1986, Journal of cellular biochemistry.

[182]  D. Stern,et al.  A pathway of coagulation on endothelial cells , 1985, Journal of cellular biochemistry.

[183]  J. Folkman,et al.  Angiogenesis is stimulated by a tumor‐derived endothelial cell growth factor , 1985, Journal of cellular biochemistry.

[184]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.

[185]  D. Loskutoff,et al.  Comparative studies of the fibrinolytic activity of cultured vascular cells. , 1979, Thrombosis research.

[186]  D. Rifkin,et al.  Isolation of a protease inhibitor from tissues resistant to tumor invasion. , 1977, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[187]  K. Havemann,et al.  Isolation of elastase-like and chymotrypsin-like neutral proteases from human granulocytes. , 1974, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.